Abstract

The aim of the present study was to investigate the effect of metabotropic glutamate receptor (mGluR) activation on gamma-aminobutyric acid (GABA) and α-melanocyte stimulating hormone (α-MSH) release from hypothalamic fragments and posterior pituitaries. The actions of a number of subtype-selective mGluR agonists were monitored. A group I mGluR agonist, ( S)-3-hydroxyphenylglycine (3-HPG; 0.5 mM), decreased K +-induced hypothalamic GABA release. ( RS)-1-Aminoindan-1,5-dicarboxylic acid (AIDA), a specific group I mGluR antagonist (0.2 mM), blocked the effect of 3-HPG. (2 S, 1′ S, 2′ S)-2-(Carboxycyclopropyl) glycine (L-CCG-I) and l-serine- O-phosphate (L-SOP; 0.01–1 mM), agonists of group II and III mGluRs, respectively, did not modify hypothalamic evoked GABA release. Group I mGluR activation decreased, whereas group III increased and group II induced no changes in GABA release from the posterior pituitary. 3-HPG (1 mM) and L-CCG-I (0.1 mM) decreased, whereas L-SOP (0.01–0.1 mM) did not change α-MSH release from hypothalamic fragments. No agonists of the three mGluR groups modified α-MSH release from the posterior pituitary. These results indicate that activation of mGluRs differentially affects GABA and α-MSH release from the hypothalamus and the posterior pituitary.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.